Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Nuclear Medicine

  Free Subscription


Articles published in Appl Radiat Isot

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    February 2026
  1. ALEZZI M, Kotbi O, Hammid G, Fouda A, et al
    Optimization of CT parameters to reduce radiation dose in SPECT/CT bone scans while preserving diagnostic quality.
    Appl Radiat Isot. 2026;231:112524.
    PubMed     Abstract available


  2. YAMAGUCHI H
    Operational redesign of medical supply management for radiopharmaceutical operations in a hospital without an SPD system.
    Appl Radiat Isot. 2026;231:112496.
    PubMed     Abstract available


    January 2026
  3. DANG P, Feng Z, Yang X, Cao X, et al
    Evaluation of exposure characteristics and radiological risks for cyclotron-based (18)F radiopharmaceutical production workers in China.
    Appl Radiat Isot. 2026;230:112474.
    PubMed     Abstract available


  4. CARVALHO CRA, Silva LB, Silva LF, Dos Santos JO, et al
    Concentration of (40)K, (226)Ra, (228)Ra and (228)Th in the main brands of pet food sold in Brazil.
    Appl Radiat Isot. 2026;230:112429.
    PubMed     Abstract available


    December 2025
  5. CARDANI I, Colucci M, Nigron E, Guertin A, et al
    Experimental cross sections and production feasibility of (61)Cu via (59)Co(alpha, 2n) for PET imaging using medium-energy alpha beams.
    Appl Radiat Isot. 2025;229:112377.
    PubMed     Abstract available


  6. KEBEDE MT, Dawud JE, Kejela BT, Gannamo MP, et al
    Assessment of radiation protection against knowledge, attitude and practice in nuclear medicine facilities in Addis Ababa, Ethiopia.
    Appl Radiat Isot. 2025;229:112372.
    PubMed     Abstract available


  7. ANDRADE EMR, Silva ACM, Ferreira AV, Gontijo RMG, et al
    A prototype of a 3D-printed zoomorphic mouse model for small animal PET scanner calibration.
    Appl Radiat Isot. 2025;229:112362.
    PubMed     Abstract available


  8. LUKUMAN B, Murat H, Said MA, Yaakob Y, et al
    Impact of body-mass-index (BMI) on effective dose of whole-body [(18)F] fluorodeoxyglucose PET/CT examinations.
    Appl Radiat Isot. 2025;229:112349.
    PubMed     Abstract available


  9. KUMAR P, Mangalore S, Joshi RK, Murthy V, et al
    Production of [(18)F]NAV4694 on an FX2N synthesis module for imaging amyloid plaques.
    Appl Radiat Isot. 2025;226:112216.
    PubMed     Abstract available


  10. ROSAR F, Petto S, Ganz S, Burgard C, et al
    Assessment of scintigraphic imaging with Terbium-161: A visual and quantitative analysis.
    Appl Radiat Isot. 2025;226:112171.
    PubMed     Abstract available


  11. ARZENTON A, Mariotti E, Scarpa D, Khwairakpam OS, et al
    Laser photo-ionization efficiency of (111)Ag for medical use in the SPES-ISOLPHARM project.
    Appl Radiat Isot. 2025;226:112143.
    PubMed     Abstract available


  12. QIU L, Bognar C, Tangadanchu VKR, Moerlein SM, et al
    Automated production of radiotracer [(18)F]FZTA for imaging sphingosine-1-phosphate receptor 1 (S1PR1) in human.
    Appl Radiat Isot. 2025;226:112136.
    PubMed     Abstract available


    November 2025
  13. NASR ZS, Shamsel-Din HA
    Aspergillic acid from Aspergillus flavus: A dual-action discovery for combatting pathogens and pinpointing inflammation via technetium-99m radiolabeling.
    Appl Radiat Isot. 2025;228:112309.
    PubMed     Abstract available


  14. KARPUZ M, Aksoyalp ZS
    A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) for therapeutic radiopharmaceuticals.
    Appl Radiat Isot. 2025;228:112306.
    PubMed     Abstract available


  15. MULLER M, Staudt M, Garcia-Vazquez R, Hvass L, et al
    Synthesis and in vivo evaluation of a polar [(18)F]BODIPY-Tetrazine as a pretargeted bimodal imaging agent.
    Appl Radiat Isot. 2025;225:112080.
    PubMed     Abstract available


  16. SIMPSON SR, Jouad K, Clay AJ, Ghosh A, et al
    Automated radiosynthesis of [(18)F]fluoromannitol on the Sofie Biosciences ELIXYS FLEX/CHEM system.
    Appl Radiat Isot. 2025;225:112076.
    PubMed     Abstract available


  17. BARBARO F, Canton L, Uzunov N, De Nardo L, et al
    Hospital-cyclotrons production of high-purity (155)Tb via (155)Gd(p,n).
    Appl Radiat Isot. 2025;225:112026.
    PubMed     Abstract available


  18. DE NARDO L, De Dominicis L, Esposito J, Rosato A, et al
    Cellular and multicellular dosimetry of two copper radioisotopes: (67)Cu and (64)Cu.
    Appl Radiat Isot. 2025;225:112041.
    PubMed     Abstract available


    October 2025
  19. ZIMMERMAN BE, Denis-Bacelar AM, Rusnak J
    Needs for radionuclide metrology in the use of alpha-emitters for radionuclide-based therapy: Summary of an International Workshop.
    Appl Radiat Isot. 2025;224:111827.
    PubMed     Abstract available


    September 2025
  20. SHAH SQ, Shirin S
    Head-to-head evaluation of DFO and 3,4,3-LI(1,2-HOPO) chelators through site-specific conjugation of Anti-STEAP1 antibody V6-19-D11 for (89)Zr-immuno-PET imaging.
    Appl Radiat Isot. 2025;226:112168.
    PubMed     Abstract available


  21. LI H, Li X, Yang L, Chen L, et al
    Sequential synthesis of [(18)F]FDG and [(68)Ga]Ga-DOTA-TATE on the AllinOne radiosynthesizer: A fully automated dual-radionuclides protocol with single cassette and reagents loading.
    Appl Radiat Isot. 2025;223:111899.
    PubMed     Abstract available


    August 2025
  22. REYES-L S, Molina-Contreras JR, Vega-Carrillo HR
    X-ray and gamma-ray shielding capacity of recycled polyethylene terephthalate (r-PET) added with barite (BaSO(4)) and metal oxide microparticles.
    Appl Radiat Isot. 2025;226:112109.
    PubMed     Abstract available


  23. AMADOR DIAZ V, Hall PM, Brown MJ, Vavere AL, et al
    Development and validation of a semi-automated [(13)N]Ammonia preparation system for clinical research.
    Appl Radiat Isot. 2025;222:111861.
    PubMed     Abstract available


    July 2025
  24. GU XB, Yu GB, Liu B, Xiang YX, et al
    A methodological study on measuring the activity of Ac-225 in targeted therapeutic radiopharmaceuticals using CdZnTe.
    Appl Radiat Isot. 2025;225:112066.
    PubMed     Abstract available


  25. CHEN J, Xie C, Wu R, Zhang D, et al
    Optimization and automation of the radiosynthesis of PET ligand targeting Abeta for imaging cerebral amyloid angiopathy.
    Appl Radiat Isot. 2025;225:112037.
    PubMed     Abstract available


  26. WANG K, Zhu X, Wang Y, Xie J, et al
    Optimization of synthesis conditions of [(68)Ga]Ga-PSMA-D5 and its clinical application in prostate cancer.
    Appl Radiat Isot. 2025;221:111825.
    PubMed     Abstract available


  27. EVANGELISTA VLO, Correia PD, Fuzato FQ, Maschio A, et al
    Simulation of the dose received by an occupationally exposed individual in the routine of a nuclear medicine service.
    Appl Radiat Isot. 2025;225:112021.
    PubMed     Abstract available


    June 2025
  28. LI J, Li C, Zheng H, Yaddanapudi K, et al
    Biodistribution studies of (89)Zr-Labeled stem cell-derived exosomes using PET imaging.
    Appl Radiat Isot. 2025;225:112000.
    PubMed     Abstract available


  29. MUNIR M, Forentin AM, Febrian MB, Fakih TM, et al
    Radiosynthesis of [(131)I]I-Hesperidin: Optimization, physicochemical profiling, and computational insights for targeted radiopharmaceuticals.
    Appl Radiat Isot. 2025;225:111977.
    PubMed     Abstract available


    May 2025
  30. ANAGNOSTOU I, Michail C, Tseremoglou S, Valais I, et al
    Examining the effect of scatter radiation spread in LaCl(3):Ce and LaBr(3):Ce scintillators under nuclear medicine imaging exposure conditions.
    Appl Radiat Isot. 2025;224:111924.
    PubMed     Abstract available


  31. SHEIKHZADEH P, Asami M, Mofrad MS, Abdolmaleki M, et al
    Organ doses, effective dose, and cancer risk estimation from whole-body CT scans in PET-CT imaging.
    Appl Radiat Isot. 2025;224:111892.
    PubMed     Abstract available


  32. YANG X, Lv G, Peng Y, Liu Q, et al
    Synthesis and biological evaluation of a (68)Ga-labeled glucose derivative PET probe [(68)Ga]Ga-NOTA-SDG.
    Appl Radiat Isot. 2025;223:111893.
    PubMed     Abstract available


    April 2025
  33. NISSIM S, Aviv O, Brandis M, Weissman L, et al
    Study of positron emission from (36)Cl.
    Appl Radiat Isot. 2025;222:111870.
    PubMed     Abstract available


  34. STEINBERG PY, Bietti FT, Gomez N, Casale G, et al
    Densitometric measurement of (18)O content of (18)O-enriched water in relation to the production of (18)F-labelled radiopharmaceuticals.
    Appl Radiat Isot. 2025;222:111848.
    PubMed     Abstract available


  35. SAPTIAMA I, Munir M, Qaira IS, Rindiyantono F, et al
    (99m)Tc radiolabeling of palm shell charcoal: A preliminary study for potential lung ventilation scintigraphy agent.
    Appl Radiat Isot. 2025;218:111689.
    PubMed     Abstract available


  36. ALHUJAILI SF, Sulieman A, Alrowaili ZA, Alshabibi ASA, et al
    Radiation dose assessment and establishment of diagnostic reference levels for MDP Tc-99m bone scans: A multi-hospital study in Saudi Arabia.
    Appl Radiat Isot. 2025;218:111695.
    PubMed     Abstract available


    March 2025
  37. KIM E, Lee C, Seo Y, Hong D, et al
    Synthesis and evaluation of a (68)Ga-labeled iodinated benzamide derivative as a PET imaging agent for malignant melanoma.
    Appl Radiat Isot. 2025;220:111791.
    PubMed     Abstract available


  38. MORTHY P, Musarudin M, Shukor NSA, Said MA, et al
    Accuracy of (177)Lu activity quantification using MCNP5-Modeled SPECT imaging.
    Appl Radiat Isot. 2025;220:111786.
    PubMed     Abstract available


  39. KHOSHYARI Z, Jahangir R, Miri-Hakimabad H, Mohammadi N, et al
    Monte Carlo-based estimation of patient absorbed dose in (99m)Tc-DMSA, -MAG3, and -DTPA SPECT imaging using the University of Florida (UF) phantoms.
    Appl Radiat Isot. 2025;220:111772.
    PubMed     Abstract available


  40. YU HM, Lin KL, Yang CH, Chan CH, et al
    Development of an (18)F-labeled 5-aroylindole derivative for histone deacetylase 6 imaging in spinocerebellar ataxia.
    Appl Radiat Isot. 2025;217:111650.
    PubMed     Abstract available


    February 2025
  41. A MOHYMEN A, Farag HI, Reda SM, Monem AS, et al
    Impact of reconstruction algorithms at different sphere-to-background ratios on PET quantification: A phantom study.
    Appl Radiat Isot. 2025;220:111761.
    PubMed     Abstract available


  42. KOBAYASHI Y, Nakamura S, Takemori M, Nakaichi T, et al
    Comparison of dose distribution with and without reflecting heterogeneous boron distribution using (18)F-BPA positron emission tomography in boron neutron capture therapy.
    Appl Radiat Isot. 2025;219:111720.
    PubMed     Abstract available


  43. NABAR SJ, Shet T, Malpani B, Hassan P, et al
    Technetium-99m-labeled stealth liposomes: A new Strategy to Identify metastasis in tumour model.
    Appl Radiat Isot. 2025;218:111709.
    PubMed     Abstract available


  44. PATRA S, Ghosh S, Singh K, Chand Sharma S, et al
    Production, radiochemical separation and electrochemical concentration of No-carrier-added (52)Mn: An emerging PET radiometal.
    Appl Radiat Isot. 2025;218:111707.
    PubMed     Abstract available


    November 2024
  45. ALOUFI KM, Gameraddin M, Alhazmi FH, Almazroui IS, et al
    Assessing radiation doses and proposing DRLs for nuclear medicine procedures for pediatric and adult patients in Madinah, Saudi Arabia.
    Appl Radiat Isot. 2024;215:111583.
    PubMed     Abstract available


    October 2024
  46. SONDERGAARD U, Thomas KE, Soborg Pedersen K, Kranz M, et al
    Production of (67)Cu at a biomedical cyclotron via (70)Zn(p,alpha)(67)Cu reaction and its evaluation in a preclinical study using small animal SPECT/CT.
    Appl Radiat Isot. 2024;215:111551.
    PubMed     Abstract available


  47. SANTOS JM, Balieiro LM, Santos RS, Matsuda MMN, et al
    Validation of chromatographic methods, TLC and HPLC, to quantify known radiochemical impurities and the radiochemical purity the radiopharmaceutical [(177)Lu]Lu-PSMA I&T.
    Appl Radiat Isot. 2024;215:111557.
    PubMed     Abstract available


    September 2024
  48. SILINDIR-GUNAY M, Ozolmez N
    Adverse reactions to therapeutic radiopharmaceuticals.
    Appl Radiat Isot. 2024;214:111527.
    PubMed     Abstract available


  49. KUMAR P, Shanbhag NC, Chaudhari P, Mohanty B, et al
    Radiolabeling and preclinical evaluation of technetium-99m labeled colistin.
    Appl Radiat Isot. 2024;214:111524.
    PubMed     Abstract available


    August 2024
  50. VASIC V, Parodi K, Pinto M
    Evaluating an analytical prediction algorithm of positron emitter distributions in patient data for PET monitoring of carbon ion therapy: A simulation study.
    Appl Radiat Isot. 2024;213:111479.
    PubMed     Abstract available


    July 2024
  51. SPAGNUOLO L, Capogni M, Fazio AA, De Felice P, et al
    National programme for the reliability of ionizing radiation measurements based on inter-laboratory comparisons (ILCs): ILC n degrees 2 'radiopharmaceutical activities'.
    Appl Radiat Isot. 2024;212:111449.
    PubMed     Abstract available


  52. WANG M, Arkins CA, Zheng QH, Glick-Wilson B, et al
    Development and validation of a HPLC method for the determination of chemical and radiochemical purity of O-(2-[(18)F]fluoroethyl-l-tyrosine ([(18)F]FET)), a PET radiotracer for the imaging of brain tumor.
    Appl Radiat Isot. 2024;212:111444.
    PubMed     Abstract available


    June 2024
  53. KANG KJ, Kim YG, Oh SJ, Won J, et al
    Determination of optimal injection dose in a small animal-dedicated positron emission tomography for non-human primate neurological studies.
    Appl Radiat Isot. 2024;211:111404.
    PubMed     Abstract available


  54. HARPER R, Morim DR, Mehta D, Rosecker V, et al
    Optimised production of technetium-94m for PET imaging by proton-irradiation of phosphomolybdic acid in cyclotron liquid target.
    Appl Radiat Isot. 2024;210:111381.
    PubMed     Abstract available


    May 2024
  55. ZOLGHADRI S, Mohammadpour-Ghazi F, Yousefnia H
    Preclinical studies and absorbed dose estimation of [(89)Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumors.
    Appl Radiat Isot. 2024;210:111379.
    PubMed     Abstract available


  56. YAZDANI E, Asadi M, Geramifar P, Karamzade-Ziarati N, et al
    A step toward simplified dosimetry of radiopharmaceutical therapy via SPECT frame duration reduction.
    Appl Radiat Isot. 2024;210:111378.
    PubMed     Abstract available


  57. VAVERE AL, Ghosh A, Amador Diaz V, Clay AJ, et al
    Automated radiosynthesis of [(18)F]DPA-714 on a commercially available IBA Synthera(R).
    Appl Radiat Isot. 2024;207:111257.
    PubMed     Abstract available


    April 2024
  58. VIERA MA, Metidieri Cruz Malthez AL
    Radioprotection in the production of (18)F-FDG at Brazilian cyclotron facilities: A comparative study based on dosimetry.
    Appl Radiat Isot. 2024;206:111189.
    PubMed     Abstract available


  59. DELLEPIANE G, Casolaro P, Gottstein A, Mateu I, et al
    (44)Sc production from enriched (47)TiO(2) targets with a medical cyclotron.
    Appl Radiat Isot. 2024;206:111220.
    PubMed     Abstract available


    March 2024
  60. RANJBAR H, Bagheri R, Miremad SM
    Evaluation of (188)Re- IBA as a novel radiopharmaceutical for bone marrow ablation.
    Appl Radiat Isot. 2024;208:111300.
    PubMed     Abstract available


    February 2024
  61. PENG L, Yang T, Zhang D, Wu R, et al
    Optimization and automation of the radiosynthesis of [(18)F]Lu-LuFL as a clinically useful PET ligand targeting FAP for tumor imaging.
    Appl Radiat Isot. 2024;207:111247.
    PubMed     Abstract available


    December 2023
  62. ASHHAR Z, Ahmad Fadzil MF, Md Safee Z, Aziz F, et al
    Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron.
    Appl Radiat Isot. 2023;205:111161.
    PubMed     Abstract available


  63. DEGUELDRE C, Findlay J, Cheneler D, Sardar S, et al
    Short life fission products extracted from molten salt reactor fuel for radiopharmaceutical applications.
    Appl Radiat Isot. 2023;205:111146.
    PubMed     Abstract available


  64. MYBURGH PJ, Moore MD, Pathirannahel BL, Grace LR, et al
    Fully automated production of [(11)C]PiB for clinical use on Trasis-AllinOne synthesizer module.
    Appl Radiat Isot. 2023;202:111040.
    PubMed     Abstract available


    November 2023
  65. KOVAN B
    The effects of kilovoltage (kV) and milliampere seconds (mAs) values for SPECT attenuation correction: An anthropomorphic phantom study.
    Appl Radiat Isot. 2023;204:111118.
    PubMed     Abstract available


  66. OZOLMEZ N, Silindir-Gunay M, Volkan-Salanci B
    An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease.
    Appl Radiat Isot. 2023;203:111110.
    PubMed     Abstract available


    October 2023
  67. SALAH H, Sulieman A, Alkhorayef M, Alkhybari E, et al
    Evaluation of personal dose equivalents during positron emission tomography and computed tomography imaging.
    Appl Radiat Isot. 2023;203:111078.
    PubMed     Abstract available


  68. DE LA FUENTE-MENDOZA JE, Azorin-Vega EP, Mendoza-Nava HJ, Rodriguez-Martinez G, et al
    Estimation of the relative biological effectiveness (RBE) of the Lu-DOTA-iPSMA177
    Appl Radiat Isot. 2023;202:111065.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum